AU1870276A - Cephalosporins - Google Patents

Cephalosporins

Info

Publication number
AU1870276A
AU1870276A AU18702/76A AU1870276A AU1870276A AU 1870276 A AU1870276 A AU 1870276A AU 18702/76 A AU18702/76 A AU 18702/76A AU 1870276 A AU1870276 A AU 1870276A AU 1870276 A AU1870276 A AU 1870276A
Authority
AU
Australia
Prior art keywords
cephalosporins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU18702/76A
Other versions
AU505141B2 (en
Inventor
David Alan Berges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of AU1870276A publication Critical patent/AU1870276A/en
Priority to AU45923/79A priority Critical patent/AU515276B2/en
Application granted granted Critical
Publication of AU505141B2 publication Critical patent/AU505141B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
AU18702/76A 1975-10-30 1976-10-14 Cephalosporins Ceased AU505141B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU45923/79A AU515276B2 (en) 1975-10-30 1979-04-09 Sulfaminoalkultetrazole thiols

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US665837 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US704142 1976-07-12
US627164 1984-07-02

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU45923/79A Division AU515276B2 (en) 1975-10-30 1979-04-09 Sulfaminoalkultetrazole thiols

Publications (2)

Publication Number Publication Date
AU1870276A true AU1870276A (en) 1978-04-20
AU505141B2 AU505141B2 (en) 1979-11-08

Family

ID=27417417

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18702/76A Ceased AU505141B2 (en) 1975-10-30 1976-10-14 Cephalosporins

Country Status (17)

Country Link
JP (1) JPS6053026B2 (en)
AT (1) AT353957B (en)
AU (1) AU505141B2 (en)
CA (1) CA1071188A (en)
CH (1) CH627757A5 (en)
DE (1) DE2649545A1 (en)
DK (1) DK463176A (en)
ES (1) ES452769A1 (en)
FI (1) FI60868C (en)
FR (3) FR2361896A1 (en)
GB (3) GB1570093A (en)
GR (1) GR61667B (en)
IE (1) IE44393B1 (en)
IL (3) IL50546A (en)
LU (1) LU76092A1 (en)
NL (1) NL7612010A (en)
SE (3) SE452621B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (en) * 1983-09-22 1987-08-25 Biochemie Gmbh Process for the preparation of monoalkali metal salts of 7-amino-3-cephem-4-carboxylic acid derivatives
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207752A1 (en) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co PROCEDURE FOR OBTAINING 7-AMINO-SUBSTITUTED-3-THIOMETHYL SUBSTITUTED-3-CEFEM-4-CARBOXYL ACIDS
NL7414119A (en) * 1973-10-31 1975-05-02 Fujisawa Pharmaceutical Co PROCESS FOR PREPARING 1H-TETRAZOL-5-THIOL DERIVATIVES AND 1-SUBSTITUATED 1H-TETRAZOL-5-THIOLS.
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
FR2351982A1 (en) 1977-12-16
FR2361896A1 (en) 1978-03-17
GR61667B (en) 1978-12-05
SE8006414L (en) 1980-09-12
AT353957B (en) 1979-12-10
DE2649545A1 (en) 1977-05-12
FR2351982B1 (en) 1981-07-03
ATA807276A (en) 1979-05-15
IL56758A0 (en) 1979-05-31
AU505141B2 (en) 1979-11-08
IL56757A0 (en) 1979-05-31
NL7612010A (en) 1977-05-03
GB1570094A (en) 1980-06-25
FI60868C (en) 1982-04-13
JPS6053026B2 (en) 1985-11-22
FR2337720A1 (en) 1977-08-05
SE437025B (en) 1985-02-04
SE8006413L (en) 1980-09-12
FR2337720B1 (en) 1981-07-10
SE452621B (en) 1987-12-07
CA1071188A (en) 1980-02-05
DK463176A (en) 1977-05-01
SE7610722L (en) 1977-05-01
JPS5257191A (en) 1977-05-11
GB1570093A (en) 1980-06-25
IL50546A (en) 1980-07-31
FI763044A (en) 1977-05-01
LU76092A1 (en) 1977-05-17
ES452769A1 (en) 1978-01-16
GB1570095A (en) 1980-06-25
IL50546A0 (en) 1976-11-30
IE44393L (en) 1977-09-11
SE435291B (en) 1984-09-17
CH627757A5 (en) 1982-01-29
FI60868B (en) 1981-12-31
FR2361896B1 (en) 1979-02-23
IE44393B1 (en) 1981-11-18

Similar Documents

Publication Publication Date Title
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1373876A (en) Bottlecap
AU1128976A (en) Magneto-alternator
AU522089B2 (en) N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine
AU508264B2 (en) Penicillins
AU501362B2 (en) Cephalosporins
AU506584B2 (en) Cephalosporins
AU501766B2 (en) Cephalosporins
GB1519237A (en) Cephalosporins
AU500339B2 (en) Penicillins
AU1191776A (en) Fluoro-prostaglandins
AU499529B2 (en) Dihydromocimycin
AU2008776A (en) Cephalosporins
AU505141B2 (en) Cephalosporins
GB1554918A (en) Cephalosporins
NZ182403A (en) Cephalosporins
AU1398876A (en) Aryl-di-thioureas
AU502402B2 (en) Cephalosporins
AU1303576A (en) Cephalosporins
KE3154A (en) Cephalosporins
AU496035B2 (en) -acylamino- -arylacetamido cephalosporins